MA46019A1 - Compositions et méthodes pour moduler l'expression de hbv et de ttr - Google Patents

Compositions et méthodes pour moduler l'expression de hbv et de ttr

Info

Publication number
MA46019A1
MA46019A1 MA46019A MA46019A MA46019A1 MA 46019 A1 MA46019 A1 MA 46019A1 MA 46019 A MA46019 A MA 46019A MA 46019 A MA46019 A MA 46019A MA 46019 A1 MA46019 A1 MA 46019A1
Authority
MA
Morocco
Prior art keywords
ttr
hbv
modulating
expression
compositions
Prior art date
Application number
MA46019A
Other languages
English (en)
Other versions
MA46019B1 (fr
Inventor
Thazha Parakash
Punit Seth
Eric Swayze
Original Assignee
Isis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Pharmaceuticals Inc filed Critical Isis Pharmaceuticals Inc
Priority claimed from PCT/US2014/036463 external-priority patent/WO2014179627A2/fr
Publication of MA46019A1 publication Critical patent/MA46019A1/fr
Publication of MA46019B1 publication Critical patent/MA46019B1/fr

Links

Landscapes

  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne des composés oligomères à groupes conjugués. Dans certains modes de réalisation de l'invention, ces composés oligomères sont conjugués à la n-acétylgalactosamine
MA46019A 2013-05-01 2014-05-01 Compositions et méthodes pour moduler l'expression de hbv et de ttr MA46019B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361818442P 2013-05-01 2013-05-01
PCT/US2014/036463 WO2014179627A2 (fr) 2013-05-01 2014-05-01 Compositions et méthodes pour moduler l'expression de hbv et de ttr

Publications (2)

Publication Number Publication Date
MA46019A1 true MA46019A1 (fr) 2020-12-31
MA46019B1 MA46019B1 (fr) 2022-08-31

Family

ID=63586942

Family Applications (2)

Application Number Title Priority Date Filing Date
MA38621A MA38621B1 (fr) 2013-05-01 2014-05-01 Compositions et méthodes pour moduler l'expression de hbv et de ttr
MA46019A MA46019B1 (fr) 2013-05-01 2014-05-01 Compositions et méthodes pour moduler l'expression de hbv et de ttr

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MA38621A MA38621B1 (fr) 2013-05-01 2014-05-01 Compositions et méthodes pour moduler l'expression de hbv et de ttr

Country Status (1)

Country Link
MA (2) MA38621B1 (fr)

Also Published As

Publication number Publication date
MA46019B1 (fr) 2022-08-31
MA38621A1 (fr) 2018-06-29
MA38621B1 (fr) 2019-04-30

Similar Documents

Publication Publication Date Title
DOP2021000095A (es) Composiciones y métodos para modular la expresión de ttr
ECSP16005566A (es) Sulfonamidas como moduladores de canales de sodio
UY35288A (es) Piridonamidas como moduladores de canales de sodio
PH12015501720A1 (en) Modulators of methyl modifying enzymes, compositions and uses thereof
UY35300A (es) Formulación de combinación de dos compuestos antivirales
UY34645A (es) Control de microorganismos fitopatogénicos con pseudomonas sp. y sustancias y composiciones derivad as de las mismas
EA201690582A1 (ru) Модуляторы фактора в комплемента
EA201692204A1 (ru) Композиции и способы модулирования экспрессии фактора комплемента b
BR112015018504A2 (pt) moduladores de flap
BR112019000356A2 (pt) compostos e métodos para modulação de smn2
CL2018001493A1 (es) Nuevos derivados de fenilo
BR112015023387A2 (pt) composições lipídicas de racecodotril
RS54733B1 (sr) Tritokvalin za upotrebu u tretiranju cistične fibroze
EA201600122A1 (ru) Новые изоиндолиновые или изохинолиновые соединения, способ их получения и фармацевтические композиции, содержащие их
EA201070448A1 (ru) Новые композиции на основе таксоидов
GEP20186893B (en) Pyrazines modulators of gpr6
IN2013DE03735A (fr)
EA201690594A1 (ru) Состав для лечения вич-инфекции на основе атазанавира и кобицистата
MA38294B1 (fr) Plaque d'amortissement réfractaire
CL2020000586A1 (es) Moduladores de la expresión de enac.
MY191993A (en) Use of isolated fractions of mastic gum for treating optic neuropathy
CL2015002188A1 (es) Agentes analgésicos oculares tópicos
MA46019A1 (fr) Compositions et méthodes pour moduler l'expression de hbv et de ttr
CY1117740T1 (el) Χρηση του odiparcil στη θεραπεια μιας μυκοπολυσακχαριδωσης
MX2021007073A (es) Composicion cosmetica.